Clinical Trials · NCT01746849
Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation
- Phase
- Phase 2
- Recruitment status
- Active Not Recruiting
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Enrollment
- 82
- Start date
- Dec 2012
- Locations
- 1 site, United States
- Primary endpoint
- a CD4+ T cell count of greater than 200